Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Barclays Bank Plc and FöreningsSparbanken AB in joint venture
Mandate

Barclays Bank Plc and FöreningsSparbanken AB in joint venture

April 26, 2005

FöreningsSparbanken, the Swedish savings bank and Barclays Bank plc, the listed British banking group have agreed to form a joint venture to sell and distribute credit cards in the Nordic market. FöreningsSparbanken will have a 60% stake in the JV and Barclays will hold the balance. The transaction is inter alia subject to approval by the Swedish FSA and the European Commission.

Vinge acted for Barclays Bank plc.
Michael Wigge (reponsible partner)
Ulrich Ziche, Dan Hanqvist (associates)

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024